AEGIS-Cure: Podophyllotoxin-Based Oncological Agent
A next-generation, targeted chemotherapy agent derived from the antimitotic compound Podophyllotoxin, found in the Himalayan Mayapple (Podophyllum hexandrum). AEGIS-Cure is designed to inhibit cancer cell division by disrupting microtubule formation, offering a potent, plant-based alternative for broad-spectrum oncological treatment.

Click Analyze to get AI-powered insights
A next-generation, targeted chemotherapy agent derived from the antimitotic compound Podophyllotoxin, found in the Himalayan Mayapple (Podophyllum hexandrum). AEGIS-Cure is designed to inhibit cancer cell division by disrupting microtubule formation, offering a potent, plant-based alternative for broad-spectrum oncological treatment.
